Literature DB >> 27207585

Fibroproliferative effect of microRNA-21 in hypertrophic scar derived fibroblasts.

Guangzao Li1, Renpeng Zhou2, Qi Zhang3, Banghong Jiang1, Qingkai Wu4, Chen Wang5.   

Abstract

Hypertrophic scar (HS) is a fibroproliferative disorder caused by abnormal wound healing, which is characterized by excessive deposition of extracellular matrix (ECM) secreted by fibroblasts. We previous have found that expression of microRNA-21(miR-21) was increased in tissues and fibroblasts of HS. However, the underlying molecular mechanism remains to be further elucidated. In this study, we identified the miR-21 was a marker for the phenotype of HS fibroblasts, as anti-miR-21 reduced expression of fibrosis markers such as Col1A1, Col3A1, Fn and α-SMA in fibroblasts and overexpression of miR-21 promoted fibroproliferative expression in fibroblasts. Furthermore, we also found that miR-21 promoted TGF-β1 induced fibroproliferative expression by repressing Smad7 expression in vitro. In addition, the miR-21 inhibitor inhibited the growth of hypertrophic scar tissue in vivo (nude mice experimental model). These results indicated that miR-21 was a critical regulator for HS formation and TGF- β1/miR-21/Smad7 pathway could be a useful therapeutic target for the treatment of HS.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fibrosis; Hypertrophic scar; MiR-21; Smad7; TGF-β1

Mesh:

Substances:

Year:  2016        PMID: 27207585     DOI: 10.1016/j.yexcr.2016.05.013

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  16 in total

1.  MicroRNA-22 may promote apoptosis and inhibit the proliferation of hypertrophic scar fibroblasts by regulating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase/p21 pathway.

Authors:  Shihua Dong; Yanfeng Sun
Journal:  Exp Ther Med       Date:  2017-08-16       Impact factor: 2.447

2.  Role of the microRNA-29 family in fibrotic skin diseases.

Authors:  Duygu Harmanci; Erdogan Pekcan Erkan; Ayse Kocak; Gul Guner Akdogan
Journal:  Biomed Rep       Date:  2017-05-03

3.  Role of hTERT rs2736100 in pathological scarring.

Authors:  Roxana Flavia Ilieș; Salomea-Ruth Halmagyi; Andreea Cătană; Casian Simon Aioanei; Istvan Lukacs; Reka-Eniko Tokes; Ioana Cristina Rotar; Ioan Victor Pop
Journal:  Exp Ther Med       Date:  2022-02-04       Impact factor: 2.447

Review 4.  Targeting microRNA for improved skin health.

Authors:  Xi Li; Sakthi Ponandai-Srinivasan; Kutty Selva Nandakumar; Susanne Fabre; Ning Xu Landén; Alain Mavon; Ia Khmaladze
Journal:  Health Sci Rep       Date:  2021-10-12

5.  MicroRNA-192 regulates hypertrophic scar fibrosis by targeting SIP1.

Authors:  Yan Li; Julei Zhang; Wei Zhang; Yang Liu; Yuehua Li; Kejia Wang; Yijie Zhang; Chen Yang; Xiaoqiang Li; Jihong Shi; Linlin Su; Dahai Hu
Journal:  J Mol Histol       Date:  2017-09-07       Impact factor: 2.611

6.  Establishment of a long-term hypertrophic scar model by injection of anhydrous alcohol: A rabbit model.

Authors:  Wenxuan Zu; Banghong Jiang; Hongwei Liu
Journal:  Int J Exp Pathol       Date:  2021-03-12       Impact factor: 1.925

7.  MiR-210-5p regulates STAT3 activation by targeting STAT5A in the differentiation of dermal fibroblasts.

Authors:  Shuyi Wei; Ye Qiu
Journal:  3 Biotech       Date:  2021-04-29       Impact factor: 2.406

Review 8.  Non-Coding RNAs: New Players in Skin Wound Healing.

Authors:  Eva K Herter; Ning Xu Landén
Journal:  Adv Wound Care (New Rochelle)       Date:  2017-03-01       Impact factor: 4.730

9.  Mir-21 Mediates the Inhibitory Effect of Ang (1-7) on AngII-induced NLRP3 Inflammasome Activation by Targeting Spry1 in lung fibroblasts.

Authors:  Na-Na Sun; Chang-Hui Yu; Miao-Xia Pan; Yue Zhang; Bo-Jun Zheng; Qian-Jie Yang; Ze-Mao Zheng; Ying Meng
Journal:  Sci Rep       Date:  2017-10-30       Impact factor: 4.379

10.  miR-211-5p inhibits the proliferation, migration, invasion, and induces apoptosis of human hypertrophic scar fibroblasts by regulating TGFβR2 expression.

Authors:  Jun Tang; Jianing Yang; Hua Hu; Ying Cen; Junjie Chen
Journal:  Ann Transl Med       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.